A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer

Cancer Hospital Chinese Academy of Medical Sciences., Beijing

Beijing Hospital, Beijing

China Medical University (CMU) First Affiliated Hospital, Shenyang

the First Hospital of Jilin University, Changchun

Harbin Medical University Cancer Hospital, Harbin

Affiliated Hospital of Nantong University, Nantong

Anhui Province Cancer Hospital, Hefei

The First Affiliated Hospital Of Shandong First Medical University, Jinan

Weifang People's Hospital, Weifang

Zhejiang Cancer Hospital, Zhejiang

The Third Hospital of Nanchang, Nanchang

Fujian Cancer Hospital, Fuzhou

Union Hospital of Tongji Medical College, Dept. of Cancer Center, Wuhan

Hubei Cancer Hospital, Wuhan

Anyang Tumor Hosptial, Anyang

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Center, Shenzhen

Jiangmen Central Hospital, Jiangmen

Guangxi Cancer Hospital of Guangxi Medical University, Nanning

West China Hospital of Sichuan University, Chengdu

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

Cancer Hospital Affliated to Xinjiang Medical University, Ürümqi

Affiliated Hospital of Hebei University, Baoding

The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang

Dongyang People's Hospital, Jinhua

Nanjing Gulou Hospital, Nanjing

Ningbo No.2 Hospital, Ningbo

Tianjin Cancer Hospital, Tianjin

Yibin Second People's Hospital, Yibin

Shanxi Provincial Cancer Hospital, Taiyuan